Last reviewed · How we verify
Meprane Dipropionate (methestrol dipropionate)
Meprane Dipropionate (generic name: methestrol dipropionate) is a methestrol dipropionate drug. It is currently in unknown development.
Meprane Dipropionate works by binding to and activating specific receptors in the body, leading to changes in gene expression and cellular function.
Meprane Dipropionate, also known as methylestrenolone dipropionate, is a synthetic steroid medication. Its exact target and mechanism of action are unknown, but it is classified as a methestrol dipropionate, a type of small molecule. The commercial status of Meprane Dipropionate is unclear, and it is not approved for any specific indications by the FDA. Further research is needed to determine its safety and efficacy. As a result, it is not widely used or available in the market.
At a glance
| Generic name | methestrol dipropionate |
|---|---|
| Drug class | methestrol dipropionate |
| Therapeutic area | Other |
| Phase | unknown |
Mechanism of action
Imagine your body's cells have locks on them, and Meprane Dipropionate is a key that fits into those locks. When it binds to the locks, it sends a signal to the cell to change what it's doing, which can help to treat certain conditions. However, the exact way it works is still not fully understood.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Meprane Dipropionate CI brief — competitive landscape report
- Meprane Dipropionate updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Meprane Dipropionate
What is Meprane Dipropionate?
How does Meprane Dipropionate work?
What is the generic name of Meprane Dipropionate?
What drug class is Meprane Dipropionate in?
What development phase is Meprane Dipropionate in?
Related
- Drug class: All methestrol dipropionate drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing